Oscar Health Reports Strong Q1 Growth with Significant Profitability Improvements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 41 minutes ago
0mins
Should l Buy OSCR?
Source: Yahoo Finance
- Significant Revenue Growth: In Q1 2026, Oscar Health reported total revenue of $4.647 billion, a 53.0% increase from $3.046 billion in Q1 2025, driven primarily by higher membership and rate increases, indicating strong performance in a competitive healthcare market.
- Improved Medical Loss Ratio: The medical loss ratio for Q1 2026 was 70.5%, down from 75.4% in Q1 2025, primarily due to the company's disciplined pricing strategy and favorable prior period reserve development, demonstrating success in managing healthcare costs.
- Substantial Operating Income Increase: The operating income for Q1 reached $704.1 million, a 137.5% increase from $297.1 million in Q1 2025, reflecting effective utilization of fixed cost leverage and increased membership, signaling enhanced future profitability.
- Net Income Surge: Oscar Health's net income for Q1 2026 was $679 million, up 146.5% from $275.3 million in Q1 2025, with diluted earnings per share reaching $2.07, showcasing a strong recovery in profitability for the company.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to fall
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 18.570
Low
11.00
Averages
15.75
High
25.00
Current: 18.570
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement: Oscar Health is set to announce its Q1 earnings on May 6 before market open, with consensus EPS estimates at $1.10 and revenue expected to reach $4.92 billion, reflecting a robust year-over-year growth of 61.3%.
- Upward Revisions: Over the past three months, EPS estimates have seen four upward revisions with no downward adjustments, indicating increased analyst confidence in the company's profitability, while revenue estimates have also been revised upward six times, showcasing market optimism about Oscar Health's future performance.
- Insider Purchase Activity: The CEO of Oscar Health recently made an insider purchase of nearly $12 million, signaling strong management confidence in the company's future, which could enhance market perception of the stock.
- Market Challenges and Opportunities: Despite challenges posed by many individuals not renewing ACA coverage after subsidy expiration, Oscar Health is still viewed as a high-growth story, with significant price discovery expected in 2026, highlighting its potential in the future market.
See More
Oscar Health Q1 2026 Earnings Beat Expectations
- Earnings Beat: Oscar Health reported a Q1 GAAP EPS of $2.07, exceeding expectations by $0.89, indicating a significant improvement in profitability that boosts investor confidence.
- Strong Revenue Growth: Despite a Q1 revenue of $4.65 billion, reflecting a 52.5% year-over-year increase, it fell short of expectations by $270 million, highlighting challenges from intensified market competition and cost pressures.
- Membership Growth: As of March 31, 2026, Oscar's total membership reached 3,174,489, a significant increase from 2,039,467 in 2025, demonstrating the company's success in market penetration and customer attraction.
- Improved Medical Loss Ratio: The medical loss ratio for Q1 was 70.5%, an improvement from 75.4% in the same quarter of 2025, indicating progress in cost control and operational efficiency, which enhances the sustainability of future profitability.
See More
Oscar Health Reports Strong Q1 Growth with Significant Profitability Improvements
- Significant Revenue Growth: In Q1 2026, Oscar Health reported total revenue of $4.647 billion, a 53.0% increase from $3.046 billion in Q1 2025, driven primarily by higher membership and rate increases, indicating strong performance in a competitive healthcare market.
- Improved Medical Loss Ratio: The medical loss ratio for Q1 2026 was 70.5%, down from 75.4% in Q1 2025, primarily due to the company's disciplined pricing strategy and favorable prior period reserve development, demonstrating success in managing healthcare costs.
- Substantial Operating Income Increase: The operating income for Q1 reached $704.1 million, a 137.5% increase from $297.1 million in Q1 2025, reflecting effective utilization of fixed cost leverage and increased membership, signaling enhanced future profitability.
- Net Income Surge: Oscar Health's net income for Q1 2026 was $679 million, up 146.5% from $275.3 million in Q1 2025, with diluted earnings per share reaching $2.07, showcasing a strong recovery in profitability for the company.
See More
Oscar Health Appoints New Board Chair
- Board Leadership Change: Oscar Health announced the appointment of independent director Siddhartha Sankaran as Chair of the Board effective June 4, 2026, succeeding Jeffery Boyd, who has served since February 2021 and is not seeking reelection, indicating a strategic shift in the company's leadership.
- Rich Industry Experience: Sankaran brings over 20 years of leadership experience in the insurance sector, having held executive roles at multiple public companies including American International Group and SiriusPoint, which is expected to enhance Oscar Health's governance standards significantly.
- CEO's Future Outlook: CEO Mark Bertolini stated that the individual market is the future of healthcare, and with Sankaran's leadership, the company is poised for its next growth phase, reflecting strong confidence in future performance.
- Contributions of Former Chair: Jeffery Boyd highlighted his contributions to Oscar's transformation over the past 12 years, expressing optimism for the company's strong performance in 2026, indicating that Oscar's leadership position in the industry will continue to strengthen.
See More
OSCAR HEALTH, INC. NAMES SIDDHARTHA SANKARAN AS INDEPENDENT CHAIR OF THE BOARD OF DIRECTORS
- New Appointment: Oscar Health, Inc. has appointed Siddhartha as an independent chair of the board.
- Leadership Change: This appointment signifies a shift in leadership within the company, aiming to enhance governance and strategic direction.
See More
Oscar Health Launches Lucie Health Marketplace to Transform Healthcare Shopping
- Innovative Healthcare Shopping Platform: Oscar Health has launched the Lucie Health Marketplace, integrating all major individual market plans and ancillary products to provide millions of entrepreneurs, employees, and retirees with more transparent healthcare choices, enhancing consumer shopping confidence.
- Personalized Insurance Bundles: Lucie allows users to customize their bundles of medical, pharmacy, and dental products according to their needs, breaking the limitations of traditional employer plans and offering more flexible financial protection, which is expected to improve users' experience with medical expenses.
- Network Coverage Advantage: Lucie's network covers almost all U.S. zip codes, forming the broadest individual plan coverage network at prices significantly lower than employer plans, which is anticipated to attract more consumers to the individual market.
- Streamlined Employer Benefits Management: Lucie enables employers to offer quality benefits at lower costs, allowing them to set budgets and provide tax-free funds to employees, simplifying the benefits management process, which is expected to enhance employee satisfaction and retention.
See More
Oscar Health Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement: Oscar Health is set to announce its Q1 earnings on May 6 before market open, with consensus EPS estimates at $1.10 and revenue expected to reach $4.92 billion, reflecting a robust year-over-year growth of 61.3%.
- Upward Revisions: Over the past three months, EPS estimates have seen four upward revisions with no downward adjustments, indicating increased analyst confidence in the company's profitability, while revenue estimates have also been revised upward six times, showcasing market optimism about Oscar Health's future performance.
- Insider Purchase Activity: The CEO of Oscar Health recently made an insider purchase of nearly $12 million, signaling strong management confidence in the company's future, which could enhance market perception of the stock.
- Market Challenges and Opportunities: Despite challenges posed by many individuals not renewing ACA coverage after subsidy expiration, Oscar Health is still viewed as a high-growth story, with significant price discovery expected in 2026, highlighting its potential in the future market.
See More
Oscar Health Q1 2026 Earnings Beat Expectations
- Earnings Beat: Oscar Health reported a Q1 GAAP EPS of $2.07, exceeding expectations by $0.89, indicating a significant improvement in profitability that boosts investor confidence.
- Strong Revenue Growth: Despite a Q1 revenue of $4.65 billion, reflecting a 52.5% year-over-year increase, it fell short of expectations by $270 million, highlighting challenges from intensified market competition and cost pressures.
- Membership Growth: As of March 31, 2026, Oscar's total membership reached 3,174,489, a significant increase from 2,039,467 in 2025, demonstrating the company's success in market penetration and customer attraction.
- Improved Medical Loss Ratio: The medical loss ratio for Q1 was 70.5%, an improvement from 75.4% in the same quarter of 2025, indicating progress in cost control and operational efficiency, which enhances the sustainability of future profitability.
See More
Oscar Health Reports Strong Q1 Growth with Significant Profitability Improvements
- Significant Revenue Growth: In Q1 2026, Oscar Health reported total revenue of $4.647 billion, a 53.0% increase from $3.046 billion in Q1 2025, driven primarily by higher membership and rate increases, indicating strong performance in a competitive healthcare market.
- Improved Medical Loss Ratio: The medical loss ratio for Q1 2026 was 70.5%, down from 75.4% in Q1 2025, primarily due to the company's disciplined pricing strategy and favorable prior period reserve development, demonstrating success in managing healthcare costs.
- Substantial Operating Income Increase: The operating income for Q1 reached $704.1 million, a 137.5% increase from $297.1 million in Q1 2025, reflecting effective utilization of fixed cost leverage and increased membership, signaling enhanced future profitability.
- Net Income Surge: Oscar Health's net income for Q1 2026 was $679 million, up 146.5% from $275.3 million in Q1 2025, with diluted earnings per share reaching $2.07, showcasing a strong recovery in profitability for the company.
See More
Oscar Health Appoints New Board Chair
- Board Leadership Change: Oscar Health announced the appointment of independent director Siddhartha Sankaran as Chair of the Board effective June 4, 2026, succeeding Jeffery Boyd, who has served since February 2021 and is not seeking reelection, indicating a strategic shift in the company's leadership.
- Rich Industry Experience: Sankaran brings over 20 years of leadership experience in the insurance sector, having held executive roles at multiple public companies including American International Group and SiriusPoint, which is expected to enhance Oscar Health's governance standards significantly.
- CEO's Future Outlook: CEO Mark Bertolini stated that the individual market is the future of healthcare, and with Sankaran's leadership, the company is poised for its next growth phase, reflecting strong confidence in future performance.
- Contributions of Former Chair: Jeffery Boyd highlighted his contributions to Oscar's transformation over the past 12 years, expressing optimism for the company's strong performance in 2026, indicating that Oscar's leadership position in the industry will continue to strengthen.
See More
OSCAR HEALTH, INC. NAMES SIDDHARTHA SANKARAN AS INDEPENDENT CHAIR OF THE BOARD OF DIRECTORS
- New Appointment: Oscar Health, Inc. has appointed Siddhartha as an independent chair of the board.
- Leadership Change: This appointment signifies a shift in leadership within the company, aiming to enhance governance and strategic direction.
See More
Oscar Health Launches Lucie Health Marketplace to Transform Healthcare Shopping
- Innovative Healthcare Shopping Platform: Oscar Health has launched the Lucie Health Marketplace, integrating all major individual market plans and ancillary products to provide millions of entrepreneurs, employees, and retirees with more transparent healthcare choices, enhancing consumer shopping confidence.
- Personalized Insurance Bundles: Lucie allows users to customize their bundles of medical, pharmacy, and dental products according to their needs, breaking the limitations of traditional employer plans and offering more flexible financial protection, which is expected to improve users' experience with medical expenses.
- Network Coverage Advantage: Lucie's network covers almost all U.S. zip codes, forming the broadest individual plan coverage network at prices significantly lower than employer plans, which is anticipated to attract more consumers to the individual market.
- Streamlined Employer Benefits Management: Lucie enables employers to offer quality benefits at lower costs, allowing them to set budgets and provide tax-free funds to employees, simplifying the benefits management process, which is expected to enhance employee satisfaction and retention.
See More
